References
- Neurath M., Fuss I., Kelsall B., Stuber E., Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 1995; 182: 1281–1290
- Neurath M., Fuss I., Kelsall B., Presky D., Waegall W., Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. Med. 1996; 183: 2605–2616
- Ehrhardt R., Ludviksson B., Gray B., Neurath M., Strober W. Induction and prevention of colonic inflammation in IL-2 deficient mice. J. Immunol. 1996; 158: 566–573
- Duchmann R., Schmitt E., Knolle P., Meyer zum Buschenfelde K. H., Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol. 1996; 26: 934–938
- Stuber E., Strober W., Neurath M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 1996; 183: 693–698
- Neurath M., Fuss I., Pasparakis M., Alexopoulou L., Haralambous S., Meyer zum Buschenfelde K. H., Strober W., Kollias G. Predominant pathogenic role of tumor necrosis factorα in experimental colitis in mice. Eur. J. Immunol., 27
- Fuss I., Marth T., Pearlstein G., Neurath M., Strober W. Anti-interleukin-12 regulates apoptosis of activated Th1 T cells in murine experimental granulomatous (TNBS) colitis. Gastroenteroloy 1997; 112: A978
- Neurath M., Pettersson S., Meyer zum Buschenfelde K. H., Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat. Med. 1996; 2: 998–1004
- Weiner H. Oral tolerance: immune mechanisms and treatment of autoimmune disease. Immunology Today 1997; 18: 335–343
- Strober W. Oral Tolerance. J. Clin. Immunol. 1998; 18: 1–30
- Seder R., Marth T., Sieve M., Strober W., Letterio J., Roberts A., Kelsall B. Factors involved in the differentiation of TGF-β-producing cells from naive CD4+ T cells: IL-4 and IFN-γ have opposing effects while TGF-β positively regulates its own production. J. Immunol. 1998; 160: 5719–5728
- Duchmann R., Kaiser I., Hermann L., Mayet W., Ewe K., Meyer zum Buschenfelde K. H. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 1995; 102: 445–447